Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer [Phase 1]
Phase 1 study evaluating motexafin gadolinium in combination with docetaxel for advanced cancers; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Gemcitabine in Ovarian Cancer [Phase 2]
A Phase 2 clinical trial of gemcitabine for ovarian cancer has completed, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-03-03Clinical Trial Update: Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers [Phase 1]
Phase 1 trial evaluating the safety and immunogenicity of CHP-HER2 and CHP-NY-ESO-1 protein vaccines with OK-432 in patients with antigen-ex…
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment [Phase 1]
Phase 1 study evaluating the safety and tolerability of CRS-207, a live-attenuated Listeria monocytogenes-based cancer vaccine, in adults wi…
-
CLINICAL_TRIALS trial_result · 2009-02-17Clinical Trial Update: The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies [Phase 3]
This is a Phase 3 clinical trial update examining preoperative psychological intervention to reduce stress in women with gynecological cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer [Phase 2]
Phase 2 trial evaluating pegfilgrastim with a multi-day topotecan regimen in relapsed or refractory ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group [Phase 2, Phase 3]
Completed phase 2/3 trial of Removab (catumaxomab) in EpCAM-positive patients with symptomatic malignant ascites, comparing with an untreate…
-
CLINICAL_TRIALS trial_result · 2009-01-23Clinical Trial Update: Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies [Phase 1]
This update describes a Phase 1 study evaluating topotecan in combination with pemetrexed in patients with advanced ovarian, endometrial, ce…
-
CLINICAL_TRIALS trial_result · 2008-11-25Clinical Trial Update: Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 safety and efficacy study of Panzem Nanocrystal Colloidal Dispersion in patie…
-
CLINICAL_TRIALS trial_result · 2008-11-07Clinical Trial Update: A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 study of D4064A for recurrent/persistent epithelial ovarian, primary peritoneal, or fallopian tube cancer is currently suspended.
-
CLINICAL_TRIALS trial_result · 2008-09-22Clinical Trial Update: Phase II CT-2103/Carboplatin in Ovarian Cancer [Phase 2]
Phase II trial of CT-2103 in combination with carboplatin for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: A Phase I Study of ECO-4601 in Patients With Advanced Cancer [Phase 1]
Phase I study of ECO-4601 in patients with advanced cancer has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: Assess Cancer in Ovarian Tumors With Biomarkers. [NA]
A biomarker-based clinical trial assessing cancer in ovarian tumors sponsored by Ciphergen Biosystems has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-09Clinical Trial Update: Examining the Long-Term Risks of Oophorectomy
This completed trial update analyzes long-term health risks after oophorectomy, including coronary heart disease, stroke, breast cancer, ova…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin [Phase 2]
Phase II results of a 72-hour continuous intravenous infusion of 9-aminocamptothecin with G-CSF support in patients with advanced ovarian ca…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients [Phase 1]
Phase I study evaluating a four-drug regimen of paclitaxel (Taxol), cisplatin, cyclophosphamide, and G-CSF in previously untreated ovarian c…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 [Phase 1]
Phase I study of infusional paclitaxel combined with the P-glycoprotein antagonist PSC 833 (valspodar) in patients with various cancers; the…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: SU5416 and Carboplatin to Treat Ovarian Cancer [Phase 1]
A Phase 1 study evaluated SU5416 in combination with carboplatin for ovarian, fallopian tube, and peritoneal cancers; the trial status shows…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Vinorelbine and XR9576 to Treat Cancer [Phase 1]
Phase 1 study evaluating the combination of vinorelbine with XR9576, a P-glycoprotein inhibitor, in patients with breast, lung, and ovarian …
-
CLINICAL_TRIALS trial_result · 2008-01-03Clinical Trial Update: Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma [Phase 2]
Phase II trial evaluating a modified triple-doublet therapy in women with newly diagnosed Mullerian carcinomas (ovarian, fallopian tube, or …
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment [Phase 2]
Phase 2 study of Ovarex (Oregovomab) monoclonal antibody with front-line chemotherapy for ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma [Phase 2]
A Phase 2 multicenter trial evaluating intravenous OvaRex MAb-B43.13 as post-chemotherapy consolidation in ovarian cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Clinical Trial for Ovarian Cancer (OvaRex®) [Phase 3]
Phase 3 trial of OvaRex for ovarian cancer has been terminated (status TERMINATED) per clinicaltrials.gov; sponsor is Unither Pharmaceutical…
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating the pharmacokinetics and safety of OvaRex MAb-B43.13 in ovarian epithelial carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer [Phase 3]
A Phase 3 trial evaluating interferon gamma-1b plus chemotherapy for ovarian cancer and peritoneal cancer was terminated; the update discuss…